UFP Technologies to Report Q4 and Year-End Results on February 24

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: Feb 19 2026

0mins

UFPT-2.98%

Should l Buy UFPT?

Source: Newsfilter

Earnings Report Schedule: UFP Technologies plans to release its fourth quarter and year-end results on February 24, 2026, after the market closes, which is expected to provide investors with critical financial data and insights into business performance.
Conference Call Timing: The company will hold a conference call on February 25, 2026, at 8:30 AM Eastern Time to discuss the earnings report in detail, aiding investors in understanding the company's future strategic direction.
Participation Details: Investors can join the call using the toll-free number 1-412-206-6478 for USA/Canada or 1-833-890-4010 for international participants, ensuring broad investor engagement and information transparency.
Webcast and Replay: A live webcast of the conference call will be available, and a replay can be accessed on the company's Investor Relations website, further enhancing the accessibility and transparency of information.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy UFPT?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on UFPT

About UFPT

UFP Technologies, Inc. is a designer and custom manufacturer of solutions for medical devices, sterile packaging, and other engineered custom products. The Company’s single-use and single-patient devices and components are used in a range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants. Its manufacturing operations consist primarily of cutting, routing, compression and injection molding, vacuum-forming, micro-molding, thermoforming, laminating, radio frequency and impulse welding, and assembling. It also engineers components for automotive use in interior trim and structural applications. These components are produced using a compression molding process to create functional composites consisting of various materials such as polypropylene/fiberglass panels, nonwovens, and fabrics. It also develops and manufactures precision thermo-formed and heat-sealed polymer components.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

UFP Technologies Shares Enter Oversold Territory

3 days agoNASDAQ.COM

Oversold Signal: UFP Technologies Inc. has an RSI of 29.9, indicating that the stock may be nearing a bottom after significant selling, prompting investors to consider buying opportunities.
Price Fluctuation: The stock hit a low of $207.475, with the current trading price at $210.58, showing some recovery from the 52-week low of $178.26, reflecting cautious optimism about its future performance.
Market Comparison: Compared to the S&P 500 ETF's current RSI of 46.1, UFP's oversold condition may attract investors looking for a rebound, highlighting a divergence in market sentiment.
Historical Performance: UFP's 52-week high is $274.93, and the current price still has a significant gap from this peak, indicating potential rebound space and investment value.

UFP Technologies Reports Q4 2025 Earnings with Strong Growth and Strategic Developments

5 days agoseekingalpha

Significant Sales Growth: UFP Technologies reported full-year sales of $602.8 million for 2025, reflecting a 19.5% increase, with CEO R. Bailly highlighting this milestone as nearly tripling revenue since 2021, indicating robust market performance.
Operational Efficiency Gains: Despite incurring $6.3 million in labor inefficiencies at the AJR facility, the company achieved a 15.4% increase in EPS for 2025, demonstrating substantial progress in onboarding and training new labor, with expectations for further improvements ahead.
Strategic Expansion Plans: The completion of a fifth building in the Dominican Republic and plans for a sixth to enhance robotic surgery capacity were underscored, with the CEO noting that a contract extension with the largest customer is projected to materially increase volumes in the coming years.
Strong Financial Performance: Cash from operations reached $92 million, with approximately $53.9 million in debt repayment, resulting in a leverage ratio of 1.1x, while gross margin decreased to 28.2% due to additional labor costs, yet adjusted operating margin remained within the target range at 17.1%.

UFP Tech (UFPT) Q4 2025 Earnings Call Transcript

5 days agoNASDAQ.COM

UFP Technologies Reports Quarterly Earnings Beat

5 days agoNASDAQ.COM

Earnings Beat: UFP Technologies reported quarterly earnings of $2.44 per share, surpassing the Zacks consensus estimate of $2.26, indicating stable profitability despite a slight decline from $2.46 a year ago.
Revenue Miss: The company posted revenues of $148.92 million for the quarter, falling short of the Zacks consensus estimate of $150.5 million, although this reflects a 3.9% year-over-year increase, suggesting ongoing market demand amid challenges.
Strong Stock Performance: UFP shares have risen approximately 8.9% since the beginning of the year, contrasting with a 0.1% decline in the S&P 500, highlighting the company's relative strength in the market and attracting investor interest.
Cautious Outlook: With current EPS estimates at $2.55 and revenue expectations at $156.63 million, management's commentary will significantly influence short-term stock movements, prompting investors to closely monitor future earnings estimate revisions.

UFP Technologies Q4 Earnings Beat Expectations

6 days agoseekingalpha

Earnings Beat: UFP Technologies reported a Q4 non-GAAP EPS of $2.44, exceeding expectations by $0.21, indicating a strong profitability trend despite revenue challenges.
Revenue Growth Lags: The company achieved Q4 revenue of $148.9 million, a 3.3% year-over-year increase, yet it fell short of market expectations by $0.17 million, highlighting competitive pressures and growth challenges.
Adjusted EBITDA Decline: Adjusted EBITDA for Q4 decreased to $28.3 million from $30.4 million in Q4 2024, suggesting challenges in cost management and operational efficiency.
Annual Improvement: For the year ending December 31, 2025, adjusted EBITDA rose to $121.1 million from $107.3 million in 2024, indicating a positive trend in overall business operations.